Notably, PTPN12, identified as a tumor suppressor gene (TSG), exhibited upregulation in our DCIS samples—contrasting with its downregulation in invasive breast cancer (IBC)—indicating its potential as a predictive biomarker for DCIS progression [32]. This evidence concerns the gene PTPN12 and ductal breast carcinoma in situ.